Navigation Links
Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2
Date:5/23/2013

gía de la compañía, y el impacto de los datos clínicos y otros datos técnicos. Las declaraciones prospectivas se basan en las actuales expectativas de la dirección y están sujetas a riesgos e incertidumbres que pueden causar que los resultados de Volcano difieran material y adversamente de las declaraciones contenidas aquí. Algunos de los posibles riesgos e incertidumbres que podrían causar que los resultados reales difieran incluyen el ritmo y extensión de la adopción de mercado de los productos y tecnologías de la compañía, resultados clínicos no esperados, incluyendo datos clínicos nuevos no esperados y análisis adicionales de datos clínicos existentes, acciones regulatorias no esperadas o retrasos o regulaciones gubernamentales, la capacidad de la compañía para mantener u obtener patentes o protección de la propiedad intelectual, competencia en general, presiones de la industria en general o de precios públicos, temas no previstos de fabricación, estrategias de crecimiento, la oportunidad y logro de hitos de desarrollo de productos, el resultado de litigios, el impacto y beneficios del desarrollo de mercado, introducciones de productos, nuevos datos no esperados, problemas de seguridad y técnicos, las condiciones del mercado y otros riesgos inherentes al desarrollo y comercialización de dispositivos médicos. Estos y otros riesgos e incertidumbres se describen totalmente en los archivos de Volcano presentados a la Comisión de Bolsa y Valores, incluyendo nuestro informe trimestral reciente en Formulario 10-Q. No debería depositarse una confianza indebida en las declaraciones prospectivas que se refieren solo a la fecha en que se realizaron. Volcano no asume obligación alguna de actualizar las declaraciones prospectivas para reflejar nueva información, eventos o circunstancias después de la fecha en que se r
'/>"/>
SOURCE Volcano Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Volcano Corporation Presentation At JMP Securities Conference To Be Webcast
2. Volcano to Highlight its Leadership in Precision Guided Therapy at EuroPCR 2012
3. Volcano Corporation Presentation At Jefferies Conference To Be Webcast
4. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
5. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
6. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
7. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
8. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
9. Volcano Corporation Presentation At Stifel Nicolaus Conference To Be Webcast
10. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
11. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... LAWRENCEVILLE, N.J. , Jan. 15, 2014  Celsion Corporation (the ... it has received commitments from institutional investors to purchase ... common stock in an at-the-market registered direct offering, led ... Company entered into definitive purchase agreements with these investors ...
(Date:1/15/2014)... 2014 Shire plc (LSE: SHP, NASDAQ: ... Trading (OFT) approval condition to the announced tender offer for all ... As a result of the waiver, the transaction is no ... tender offer on January 24, 2014 following the currently scheduled expiration ...
(Date:1/15/2014)... , January 15, 2014 BreedIT ... the exclusive worldwide distributor of highly sophisticated agro-breeding solutions ... January 7, 2014, the Company,s board of directors appointed ... as its new member of the board. ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
... SILVER SPRING, Md., June 14, 2011 The U.S. ... test that will help health care professionals determine if ... for Herceptin (trastuzumab), a commonly used breast cancer treatment. ... The test, called Inform Dual ISH, allows for measurement ...
... June 14, 2011 Viral Genetics, Inc. (Pinksheets: ... clinical-stage company. The Company,s two lead pharmaceutical programs ... (MDT) compounds for drug-resistant cancers -- are being ... Investigational New Drug (IND) pathways. An IND application ...
Cached Medicine Technology:FDA Approves New Test To Help Determine if Breast Cancer Patients Are Candidates for Herceptin Treatment 2FDA Approves New Test To Help Determine if Breast Cancer Patients Are Candidates for Herceptin Treatment 3Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs 2Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs 3Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs 4
(Date:4/22/2014)... percent of all lung cancers are small cell ... develop resistance to chemotherapy. However, researchers at Virginia ... insights into the mechanisms leading to this resistance ... Chemotherapies work primarily by mediating B-cell lymphoma 2 ... cell death. Depending on their function, this family ...
(Date:4/22/2014)... Hopkins scientists have found a way to block abnormal ... of atherosclerosis, the main cause of heart attacks and ... The condition develops when fat builds inside blood vessels ... greatly reducing their ability to feed oxygen-rich blood to ... series of experiments, described April 7 in the journal ...
(Date:4/22/2014)... spending, a new RAND study concludes that U.S. policy ... and device makers to develop products that produce more ... their use, a new study suggests the study identifies ... created in the first place. The aim is to ... of health as possible and to ensure that costlier ...
(Date:4/22/2014)... nanodot technology, Berkeley Lab researchers have demonstrated the ... used to study the membranes of living cells. ... structures can reveal information critical to whether a ... cancerous, that can,t be obtained through conventional microscopy. ... provide a physical means to both probe and ...
(Date:4/22/2014)... been approved since November 2013 for the prevention and ... an early benefit assessment pursuant to the "Act on ... the German Institute for Quality and Efficiency in Health ... an added benefit over the appropriate comparator therapy. ... turoctocog alfa is not proven. As no relevant study ...
Breaking Medicine News(10 mins):Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 3Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 4Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3Health News:First size-based chromatography technique for the study of livi 2Health News:First size-based chromatography technique for the study of livi 3Health News:Turoctocog alfa in patients with hemophilia A: Added benefit not proven 2Health News:Turoctocog alfa in patients with hemophilia A: Added benefit not proven 3
... has introduced a new law by which the consumers using ... of the drugs, toxicity levels and the safety of these ... consumers with labelled information about the quality and safety of ... allow registering of the new drugs without approval about the ...
... Minister of Information, Broadcasting and Culture, India has asked ... the prevention and treatment of HIV infections. // He ... The media could play an important role in spreading ... broadcasting tools such as radio, websites, SMS, Television programs ...
... In what may sound as a typical open-and-shut case, a ... sexual assault// and a blood sample from a known criminal. ... assault took place. Forensic scientists had already matched the crime ... their prime suspect. It was only after careful detective work ...
... and his team from International Agency for Cancer Research ... cabbages reduces the incidence of lung cancer. ,The ... and 2,168 healthy individuals from Poland, Slovakia, Czech Republic, ... normal part of the diet. The study has found ...
... that boys face more mathematics learning disorders than girls.// ... seemingly unexplained difficulty a person of at least ... skills are essential for success at school, work and ... the first time William Barbaresi, a developmental and behavioral ...
... the womb and early childhood can predict development// of heart ... birth weight under 6.6 pounds, a body mass index (BMI) ... at age 11 with a significantly increased risk of heart ... three times more likely to develop heart problems as those ...
Cached Medicine News:Health News:DNA Identity Mix-Up In Bone Marrow Donors, And Miscarriages Of Justice Involved 2Health News:Cabbage And Genes May Protect Against Lung Cancer 2Health News:Early Growth Patterns Can Predict Heart Disease 2
...
... II is a semi-automated, ... standardised reflectance photometric test-strip-evaluation. ... features allow user friendly ... convenience to supply immediate ...
... The Assistant Free ... retractors utilizing Velcro® straps. ... of the surgeon's operative ... personnel. Three retractor styles ...
... is designed for four corner fusion of ... in the hand. The plate is intended ... and/or loss of function due to SLAC ... instability or rheumatoid arthritis. When combined with ...
Medicine Products: